Patrick Link, PhD

Patrick Link, PhD

Mayo Clinic

Research Project:
Myeloperoxidase Promotes Persistent Fibrosis

Grant Awarded:

  • Dalsemer Grant

Research Topic:

  • basic biologic mechanisms

Research Diseases:

  • interstitial lung disease
  • pulmonary fibrosis

Pulmonary fibrosis (PF) is a progressive fatal lung disease expected to increase dramatically due to post-COVID complications. In human disease and experimental models, it remains unclear what separates normal wound healing from progressive lung scarring and persistent disease. An enzyme called myeloperoxidase increases in PF and has been correlated with rapid deterioration of pulmonary fibrosis patients. Myeloperoxidase contributes to fibrosis in other major organ systems as well. Whether myeloperoxidase contributes to PF progression and prevents resorption of scar tissue is unknown. We will use laboratory tests and animal models of PF to determine the role of this enzyme in PF and determine if it is a potential target for treatment.

Page last updated: October 3, 2023

Freedom From Smoking Clinic
Detroit, MI | May 29, 2024
Asthma Basics Workshop - National
, | Jun 18, 2024